Northwest Biotherapeutics Inc (NWBO)
0.2901
0.00 (0.00%)
USD |
OTCM |
Nov 14, 15:59
Northwest Biotherapeutics Shareholders Equity (Quarterly): -76.50M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -76.50M |
March 31, 2024 | -73.28M |
December 31, 2023 | -65.77M |
September 30, 2023 | -65.12M |
June 30, 2023 | -61.03M |
March 31, 2023 | -55.98M |
December 31, 2022 | -128.10M |
September 30, 2022 | -108.85M |
June 30, 2022 | -91.67M |
March 31, 2022 | -120.52M |
December 31, 2021 | -123.99M |
September 30, 2021 | -301.73M |
June 30, 2021 | -349.84M |
March 31, 2021 | -353.20M |
December 31, 2020 | -362.95M |
September 30, 2020 | -212.43M |
June 30, 2020 | -81.32M |
March 31, 2020 | -34.99M |
December 31, 2019 | -45.06M |
September 30, 2019 | -54.54M |
June 30, 2019 | -53.01M |
March 31, 2019 | -58.50M |
December 31, 2018 | -47.16M |
September 30, 2018 | -47.14M |
June 30, 2018 | -63.79M |
Date | Value |
---|---|
March 31, 2018 | -63.02M |
December 31, 2017 | -47.29M |
September 30, 2017 | -42.83M |
June 30, 2017 | -35.24M |
March 31, 2017 | -36.64M |
December 31, 2016 | -26.50M |
September 30, 2016 | -5.022M |
June 30, 2016 | -18.97M |
March 31, 2016 | -6.193M |
December 31, 2015 | -4.676M |
September 30, 2015 | -57.36M |
June 30, 2015 | -76.17M |
March 31, 2015 | -70.70M |
December 31, 2014 | -35.03M |
September 30, 2014 | -31.22M |
June 30, 2014 | -29.87M |
March 31, 2014 | -31.06M |
December 31, 2013 | -9.818M |
September 30, 2013 | -25.08M |
June 30, 2013 | -27.25M |
March 31, 2013 | -28.05M |
December 31, 2012 | -16.07M |
September 30, 2012 | -38.10M |
June 30, 2012 | -30.66M |
March 31, 2012 | -24.82M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-362.95M
Minimum
Dec 2020
-34.99M
Maximum
Mar 2020
-142.75M
Average
-91.67M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 27.65M |
Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 28.22M |
Total Liabilities (Quarterly) | 104.72M |
Debt to Equity Ratio | -0.6672 |
Current Ratio | 0.0886 |
Net Debt Paydown Yield | -0.93% |